-
Article
Open AccessLocalized fine-tuning and clinical evaluation of deep-learning based auto-segmentation (DLAS) model for clinical target volume (CTV) and organs-at-risk (OAR) in rectal cancer radiotherapy
Various deep learning auto-segmentation (DLAS) models have been proposed, some of which have been commercialized. However, the issue of performance degradation is notable when pretrained models are deployed in...
-
Article
Open AccessPyrotinib and trastuzumab plus palbociclib and fulvestrant in HR+/HER2+ breast cancer patients with brain metastasis
Human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC) patients are at a high risk of develo** metastases in the brain. However, research focusing on treatment strategies for hormonal r...
-
Article
Open AccessGenetic analysis of oligo-recurrence breast cancer: correlation with clinical outcomes
We aimed to identify the relationship between the genomic characteristics and clinical outcomes of oligo-metastatic breast cancer.
-
Article
Open AccessThe interplay between N6-methyladenosine and precancerous liver disease: molecular functions and mechanisms
N6-methyladenosine(m6A) is one of the most abundant modifications of mammalian cellular RNAs. m6A regulates various biological functions in epitranscriptomic ways, including RNA stability, decay, splicing, transl...
-
Article
Open AccessThe prognostic value and immune microenvironment association of AR in HER2+ nonmetastatic breast cancer
This study aimed to investigate the prognostic value of AR in HER2+ nonmetastatic breast invasive ductal carcinoma (IDC) and its relationship with the immune microenvironment. HER2+ nonmetastatic breast IDC pa...
-
Article
Open AccessThe diagnostic and prognostic implications of PRKRA expression in HBV-related hepatocellular carcinoma
Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) accounts for more than half of total HCC patients in develo** countries. Currently, HBV-related HCC diagnosis and prognosis still lack specific ...
-
Article
Open AccessRetro-enantio isomer of angiopep-2 assists nanoprobes across the blood-brain barrier for targeted magnetic resonance/fluorescence imaging of glioblastoma
Glioblastoma (GBM), one of the most common primary intracranial malignant tumours, is very difficult to be completely excised by surgery due to its irregular shape. Here, we use an MRI/NIR fluorescence dual-mo...
-
Article
Open AccessThe STING1 network regulates autophagy and cell death
Cell death and immune response are at the core of life. In past decades, the endoplasmic reticulum (ER) protein STING1 (also known as STING or TMEM173) was found to play a fundamental role in the production of...
-
Article
Open AccessCPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4
-
Article
Open AccessComorbidity in lung cancer patients and its association with hospital readmission and fatality in China
Comorbidity has been established as one of the important predictors of poor prognosis in lung cancer. In this study, we analyzed the prevalence of main comorbidities and its association with hospital readmissi...
-
Article
Open AccessComorbidity in lung cancer patients and its association with medical service cost and treatment choice in China
It is evident that comorbidity exacerbate the complexity of the management of lung cancer, however, limited research has been conducted to investigate the impact of comorbidity on health service utilization an...
-
Article
Open AccessThe chromosome 11q13.3 amplification associated lymph node metastasis is driven by miR-548k through modulating tumor microenvironment
The prognosis for esophageal squamous cell carcinoma (ESCC) patients with lymph node metastasis (LNM) is still dismal. Elucidation of the LNM associated genomic alteration and underlying molecular mechanisms m...
-
Article
Open AccessErratum to: 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells
-
Article
Open Access53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells
Mutations in DNA damage response factors BRCA1 and BRCA2 confer sensitivity to poly(ADP-ribose) polymerase (PARP) inhibitors in breast and ovarian cancers. BRCA1/BRCA2-defective tumors can exhibit resistance t...